As digital healthcare grows, obtaining medications like Zepbound through online prescriptions has become increasingly popular ...

Diabetes drug Mountjaro has been on the list since 2022 and weight-loss drug Zepbound was added in April. The shortage has forced consumers to turn to drug compounders, who make equivalent ...

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been resolved. Tirzepatide, the active ingredient in the diabetes and ...

Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro to treat diabetes, has been in short supply since 2022 amid skyrocketing demand. The medication is part of the blockbuster ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Zepbound (tirzepatide) is a prescription drug that’s used for weigh loss in certain adults. The drug comes as a liquid solution inside prefilled injection pens. Zepbound is not safe to use while ...

By Dani Blum The Food and Drug Administration on Wednesday declared an end to the two-year shortage of tirzepatide, the substance in the popular weight-loss medication Zepbound and the diabetes ...

Diabetes treatment Mounjaro has been on the health regulator's shortage list since late 2022, while weight-loss drug Zepbound was added in April as demand far outstripped supply. The limited ...

Eli Lilly's $4.5 billion investment aims to expand its drug pipeline and build on the success of Mounjaro and Zepbound. Despite short-term stock volatility, long-term prospects remain bullish as ...

Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources ...